Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year book value per share growth
Latest
-27.50%
↓ 384% vs avg
Percentile
P26
Within normal range
Streak
3 qtr
Consecutive declineDecelerating
Average
9.67%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -27.50% |
| Q2 2025 | -26.00% |
| Q1 2025 | -21.56% |
| Q4 2024 | -14.61% |
| Q3 2024 | -15.55% |
| Q2 2024 | -7.41% |
| Q1 2024 | 19.47% |
| Q4 2023 | -18.27% |
| Q3 2023 | -20.44% |
| Q2 2023 | -9.06% |
| Q1 2023 | -14.02% |
| Q4 2022 | -9.40% |
| Q3 2022 | -13.25% |
| Q2 2022 | 5.97% |
| Q1 2022 | -8.96% |
| Q4 2021 | -8.40% |
| Q3 2021 | -6.32% |
| Q2 2021 | 3.36% |
| Q1 2021 | 15.36% |
| Q4 2020 | 13.37% |
| Q3 2020 | -34.03% |
| Q2 2020 | 756.81% |
| Q1 2020 | -49.29% |
| Q4 2019 | -43.72% |
| Q3 2019 | -41.30% |
| Q2 2019 | 127.31% |
| Q1 2019 | -40.69% |
| Q4 2018 | -26.68% |
| Q3 2018 | -33.19% |
| Q2 2018 | -36.19% |
| Q1 2018 | 59.08% |
| Q4 2017 | -38.36% |
| Q3 2017 | 64.46% |
| Q2 2017 | -33.80% |
| Q1 2017 | -29.04% |
| Q4 2016 | 8.66% |
| Q3 2016 | -27.25% |
| Q2 2016 | -9.40% |
| Q1 2016 | -8.72% |
| Q4 2015 | -14.43% |